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The plaicizerdi(2eCthylhexyl) phthalate (DEHP) iswidely used in buildingmaterials. DEHP is
identified as the major plasticizer exposure in dwellings. We provide evidence that inhalation
exposure to DEUP as aerosols adsorbed toparticulate matter is as important, or moreimportant,
than vaporphase exposure. The particulate in io exposure to DEHP is considered to besig
nificant due to its low clearance and extnsive penetration into the pulmonaryregion. DEHP is
capable ofcetinghigh local concentrations in theairways at thedeposiion sitewith subsequent
local effects. The proposed mechanism ofeffect states that mono(2-ethylhexyl) phthalate
(MEHP), the primary hydrolysis product ofDEHP, mimics the inducing p andins (PG)
PGD2, 9a,l 1PPGF2, andPGF2., and thromboxanes in the lungs, thereby increasi the risk of
inducing infmmation in the airways, which is a charcteristc ofastuia Riy work asthma,
di(2-ethylhexyl) phthalate, mono(2-ethylhexyl) phthalate, plasticizer, polyvinyl chloride,
prostandin, PVC, thrmboxaneA2 receptor.
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Industrialization has been accompanied by
a notable increase in the occurrence of
unnatural substances (xenobiotics). Many
of these environmental chemicals decom-
pose very slowly and some of them even
have bioaccumulative properties. The expo-
sure to xenobiotics results in an increased
risk of detrimental effects to health. The
extent of this risk is illustrated by recent
discoveries of different xenobiotics exhibit-
ing estrogenlike effects. This might result in
lower sperm counts, epididymal cysts, cryp-
torchidism, and testicular cancer (1).
Parallel to this, several studies indicate
an increased rate of diagnosed asthma
among children during the last 30 years
(2-8). There has been some controversy
whether this increase has been due to a gen-
uine increase in asthma or simply to a
change in diagnostic criteria. In several
industrialized countries, airway inflamma-
tion and bronchial reactivity have been
observed, including childhood asthma,
which affects from 11 to 20% of all chil-
dren of school age (9). Not only is asthma
common but the incidence appears to be
steadily increasing; from recent reviews, it
seems that the incidence of asthma is dou-
bling every 10-15 years (2,10). Ifthis trend
is to be halted, it is necessary to determine
the causal factors and to understand the
underlying mechanisms.
Outdoor aswell as indoorpollutants have
been suggested as risk factors in the develop-
ment of asthma. Outdoor air pollution has
been dedining in certain industrialized coun-
tries during the last 10 years (11), but con-
trary to expectation, this has not resulted in a
corresponding decline in the incidence of
asthma. It is therefore a possibility that
indoor pollutants might be ofgreater impor-
tance in the development of asthma than
outdoor pollutants. Several studies have
shown significant associations between
health outcomes and exposure to indoor
components like environmental tobacco
smoke (12-15), NO2 (16), mite allergens
(17-19), and mold or dampness (20-24).
Also, other residential exposures such as pet
allergens and particles have been suggested
to cause health problems (25,26).
Inflammation of the airways is an
important part ofthe mechanism ofasthma
and bronchial reactivity (27). Most aller-
gens stimulate production ofIgE antibodies
that bind to mast cells; with linkage to anti-
gens, the mast cells release inflammatory
mediators, causing bronchospasm and
mucus production. There also appears to be
chemical compounds with a capacity to
trigger the inflammation without involving
IgE (28). Long-term occupational exposure
to relatively high levels ofchemicals such as
formaldehyde (29), diisocyanates (30), and
organic anhydrides (31) is known to
increase the risk of asthma. Exposure to
some ofthese chemical compounds, such as
formaldehyde, may also lead to develop-
ment of specific airway hypersensitivity
(29,32). Organic acid anhydrides, com-
monly used for production ofplasticizers in
the plastic industry, have been suggested to
induce production of IgE antibodies (31).
Little is known about whether the levels of
chemical compounds common in the home
environment play any role in the causation
of bronchial obstruction and asthma.
Plastic interior materials are potential
sources of chemicals that may cause airway
inflammation and increase the risk of
bronchial obstruction and asthma. Recently,
exposure to plastic interior surfaces have
been shown to increase the riskofdeveloping
bronchial obstruction during the first 2 years
of life Jaakkola et al., unpublished data).
However, little is known about the active
agent(s), exposure route(s), andpathogenesis.
The plasticizer di-(2-ethylhexyl) phtha-
late (DEHP) is widely used in the produc-
tion of polyvinyl chloride (PVC) and vinyl
chloride resins. DEHP accumulates, to a
great extent, in building interior surfaces
(33,34). Further, mono(2-ethylhexyl)
phthalate (MEHP), the primary hydrolysis
product of DEHP, has been found to
induce bronchial hyperreactivity in rats (35).
Jaakkola et al. (unpublished data) recently
observed an association between plastic inte-
rior surfaces and bronchial obstruction and
suggested DEHP as a possible active agent,
without going into possible mechanisms.
The objective of the present study was to
identify and quantify the major phthalate
inhalation exposure routes in residences. We
propose a hypothesis on the role of DEHP
in the pathogenesis ofasthma.
Materials and Methods
Samples. Materials were selected from the
Oslo Birth Cohort Study, which is a study
of 3,754 children born in Oslo, Norway,
1992-1993 (36). From a total of 372
dwellings with performed site inspections
and ventilation measurements, 38 dwellings
were selected for another study (3X, but
additional samples of sedimented dust and
suspended particulate matter were taken for
the present study. Briefly, the criteria for
inclusion ofthe dwellings under study were
1) equal representation of residences with
predicted high or low suspended particulate
matter concentrations and 2) that the occu-
piers had not moved or renovated their resi-
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dences since the site inspection in the Oslo
Birth Cohort Study. The summer season
(une to August) was excluded as a measur-
ing period due to extensive airing. The
families were urged not to perform any
interventions before the end of collection
ofsamples and suspend any housecleaning
procedures for 7 days prior to our sched-
uled site visit.
Sedimented dust samples. Sedimented
dust was collected on Millipore aerosol
analysis monitors, type A (Millipore,
Bedford, MA). The main filter was a
Millipore AP40 integral filter made of
borosilicate microfibre glass with a diameter
of24 mm, with 0.8-8 pm pores, and with-
out binder material. Acellulose prefilter pad
was used to support the main filter and to
facilitate an even airflow over the filter area.
The inlet on the monitor housing was
equipped with a Teflon tube. The outlet
was connected to a conical silicone adapter
to fit the tube ofa standard vacuum cleaner
operating at 500 W. After sampling, the fil-
ters were stored in sealed glass containers in
a refrigerator untilweighing and analysis.
Each sedimented dust sample is a
pooled sample from the following loca-
tions: sheet of child's bed (1 min sam-
pling), floor in child's bedroom (1 mi2, 1
min sampling), floor in central living room
(1 m2, 1 min sampling), and on top of
shelves in central living room (0.5 m2, 0.5
min sampling).
Suspendedparticulate matter samples.
For comparison of sedimented dust and
suspended particulate matter with respect
to contents ofphthalates, 6 residences were
randomly selected out ofthe total of38 for
additional sampling of suspended particu-
late matter. The families were urged not to
perform any interventions before the end
of the 7-day sampling period and not to
perform any housecleaning procedures dur-
ing sampling.
Suspended particulate matter was collect-
ed on Millipore MHTSO25AC filters
(Millipore). The main filter was made of
polycarbonate, with adiameterof37 mm and
with 0.4 pm pores. A cellulose prefilter pad
was used to support the main filter and to
facilitate an evenairflowoverthefilter area.
For quantitative assessment of the sam-
pled material, the polycarbonate filters were
weighed before and after sampling on a
Mettler MT5 microbalance, with a readabili-
ty and reproducibility of 1 pg and 0.8 pg,
respectively. Before and after sampling, the
filters were maintained in a controlled envi-
ronment (temperature, 22°C; relative humid-
ity, 50%) for atleast 12 hrpriortoweighing.
All samples of suspended particulate
matter were collected with the full opening
in the filter cassettes directed approximately
450 downward. From each dwelling, two
parallel samples were collected in the same
position in the central living room, 1.1 m
above the floor and above the table allocat-
ed to the most frequently used sitting
group. The field monitors were connected
by silicone tubes to net-operated high flow
pumps (Dymax 30; Charles Austen Ltd.,
Surrey, U.K.) with an initial capacity of5.0
1/min without external resistance. The actu-
al flows were measured on site at the start
and stop of each measurement by a flow-
meter.
Analysis ofphthalate esters adsorbed to
sedimenteddust andsuspendedparticulate
matter. After weighing, the sedimented
dust samples were transferred from the fil-
ter units to 5 ml glass vials with Teflon-
lined screw caps. Depending on the sample
size, 0.5-2.0 ml of methanol (1.0 ml in
most cases) was added. The mixture was
thoroughly stirred with a glass rod and left
for extraction without stirring at room
temperature for 24-48 hr; it was then
stirred again and centrifuged. The clear
supernatant was analyzed with gas chro-
matograpy-mass spectrometry (GC-MS).
The samples of suspended particulate
matter, in the form of two filters with the
adherent fine dust from each ofthe six resi-
dences, were extracted with 0.5 ml of
methanol for 24-48 hr in the same type of
vials used for sedimented dust. The vials
were placed horizontally to ensure wetting
ofthe dust filters.
The sedimented dust samples, left sus-
pended in methanol after extraction as
described above, were further suspended in
water (50 ml) with shaking. After a few
minutes ofsedimentation ofdense particles
(sand, soil, etc.), as much as possible ofthe
remaining suspension of organic material
was removed. The process was repeated 10
times. The inorganic fraction obtained was
isolated on a preweighed membrane filter,
dried in an oven at 40°C for 30 min, and
weighed.
The gas chromatograph (Hewlett-
Packard 5890; Hewlett-Packard, Palo Alto,
CA) was equipped with a standard
split/splitless injector and coupled to a VG
Trio-2 quadrupole mass spectrometer. The
column used was a 30 m x 0.31 mm inner
diameter DB-5 fused silica column U&W
Scientific) with a film thickness of 1 pm.
Helium was the carrier gas, with a flow rate
of about 2 ml/min. The oven temperature
was 100°C for 2.5 min, followed by a rise
of 10°C/min to 3000C. The final tempera-
ture was held for 8 min. The injector and
transfer line temperatures were 275°C.
Splitless injections of 1 pl of samples and
standards were performed with the splitflow
closed for 1 min, and with the aid of the
solvent flush technique, in which the
syringe needle is filled with solvent
(methanol) followed by an air plug and the
sample. After a solvent delay time of 2.5
min, the mass spectrometer was set to scan
full spectra in the positive ion electron
impact mode in the mass range m/z20-350
at a speed of 1 scan/sec. Data were acquired
on a personal computer with the Labbase
software (VG, Mancester, U.K.).
Results
The weight ofthe 38 sedimented dust sam-
ples ranged from 40 to 609 mg (median =
147 mg). Inspection of the filters revealed
the presence ofvarying, and often substan-
tial, amounts of large particles (sand, soil,
etc.), which could bias the results. The
weight of the organic fraction, determined
by separating and weighing the inorganic
fractions, ranged from 27 to 378 mg (medi-
an = 119 mg), accounting for 41-92%
(mean = 76%) ofthe total sedimented dust.
The accumulated weight of the six parallel
suspended particulate mattersamples ranged
from 838 to 2655 pig (median = 1534pig).
Chromatographic traces from the analy-
sis of the methanol extract of a sedimented
dust sample are shown in Figure 1. The
total ion current chromatogram, lower trace,
shows that the extract is not very complex.
The major constituents are the phthalate
esters and a number ofcompounds of sup-
posed biological (human) origin, including
fatty acids and the triterpenoid hydrocarbon
squalene, which is secreted from human skin
at a rate of250 mg/day in adults (38). The
composition of the extracts is qualitatively
rather constant. See Figure 1 for a list of
common constituents.
The quantification of the phthalate
esters was based on mass chromatograms of
their characteristic m/z 149 ion peaks (Fig.
IA). The amounts ofthe three most promi-
nent esters, dibutyl, benzyl butyl, and di(2-
ethylhexyl), were determined with the aid
of external standard calibrations with four
solutions in methanol in the concentration
range 2-200 ppm (pg/ml). With the use of
mean values from two to five injections of
each standard solution, very good linear cal-
ibration lines were obtained (r2 values of
0.9998 or better), but standard deviations
were rather large, about 25%. The generally
minor amounts of diethyl and diisobutyl
esters were quantified with the calibration
for the dibutyl ester. The heavier phtha-
lates, appearing to be a mixture ofisomeric
dinonyl esters, were present in a few ofthe
samples. These were quantified with di(2-
ethylhexyl) ester as standard.
The extraction solvent, methanol, seems
to be adequate in the sense that reextraction
of a sedimented dust sample for 24 hr
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showed that all methanol-extractable phtha-
late ester material had been removed in the
first extraction. Further validation of the
method induded blind analyses offilters and
housings. The extract offilters an+housing
for sedimented dust contained a considerable
amount ofdioctyl adipate as the only back-
ground component, but this ester was not
present in the sample extracts. The extract of
filters and housing for suspended particulate
matter showed no background material
except for barely detectable amounts of
dibutyl phthalate (DBP) and DEHP, that
mostlikely represent asyringe memoryeffect.
Table 1 shows the distribution ofphtha-
lates adsorbed to sedimented dust. There is a
large variation in concentrations ofall species
of phthalates in sedimented dust. DEHP is
the predominant phthalate species in both
total dust (64 pg/100 mg) and organic frac-
tion (82 pg/100 mg). In the 38 samples of
sedimented dust, DEHP accounts for
32-97% (mean 69%) of the total amounts
of phthalates in total dust. DBP, benzyl
butyl phthalate (BBP), and the heavier
phthalates (mixture of isomeric dinonyl
phthalates) each account for approximately
10% ofthe total amount ofphthalates. The
amounts of diethyl phthalate (DEP) and
diisobutyl phthalate (DIBP) are negligible in
most residential sedimented dust samples.
Table 2 shows the distribution ofphtha-
lates adsorbed to suspended particulate mat-
ter. As in sedimented dust, there is a large
variation in concentrations of all species of
phthalates in suspended particulate matter.
DEHP is the predominant species in the
samples ofsuspended particulate matter (60
pg/100 mg) followed by DBP, BBP, and
DEP. In the six samples of suspended par-
ticulate matter, DEHP accounts for 52% of
total phthalates. DIBP and heavier phtha-
lates were not found in a
ticulate matter samples
phthalates to suspended p
ofthe same magnitude as
100%
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A normal active adult inhales 14 m3 of
air in 24 hr (39). With an exposure to sus-
pended particulate matter (PMI) of 90
pig/m3 [national 8-hr averageguideline (40)],
the particulate exposure to DEHP will be
0.30-1.18 pg/day (mean 0.76 pg/day)
according to our measurements of DEHP
particle exposure.
As shown in Table 3, a significant cor-
relation was found between the concentra-
tions of the plasticizers DEHP and BBP
adsorbed to suspended particulate matter
and the corresponding concentrations
adsorbed to both total and organic fraction
of sedimented dust. For the dominating
plasticizer, DEHP, a scatter plot displaying
the correlation is presented in Figure 2.
Discussion
my suspended par- Residentialexposure tophthalates. DEHP is
s. The affinity of identified as the major phthalate exposure
)articulate matter is compound, both in sedimented dust and in
sedimented dust. suspended particulate matter. On average,
DEHP accounts for 69% of the total
amount ofphthalates adsorbed to sediment-
ed dust and for 52% ofsuspended particu-
late matter. A large variation in amounts of
phthalates adsorbed to both sedimented
dust and suspended particulate matter was
found, indicating an equally large variation
in exposure. The samples of sedimented
dust could be biased by particles from PVC
1,400 1,600 flooring or other materials containing plas-
ticizers. However, this is not likely to be the
case for the plasticizers DEHP and BBP
because there is a significant correlation
between concentration in suspended partic-
ulate matter and in sedimented dust sam-
ples. This indicates that sedimented dust
samples are good surrogates of suspended
particulate matter samples with respect to
adsorbed DEHP and BBP.
200 400 600 800 1,000 1,200 1,400 1,600 Because of very slow volatilization of
Scan number DEHP from plastic products, the airborne
human exposure is estimated to be 0.4
lass chromatogram (mlz 149) and (B) total ion current chromatogram of the methanol pg/day (41). In these calculations, only the
iimented dust sample. Major components by scan number and name are 677, dodecanoic vapor h
yl phthalate; 828, tetradecanoic acid; 897, pentadecanoic acid; 913, diisobutyl phthalate leads to underestimation ofreal exposure. In ioic acid; 976, dibutyl phthalate; 1079, octadecenoic acid; 1090, octadecanoic acid; 1216, thisstudy wehaveshown thatthe residential thalate; 1326, di(2-ethylhexyl) phthalate; 1556, squalene.
Table 1. Phthalate concentrations adsorbed to sedimented dust(total and organic fraction) in 38 dwellings in
Oslo, Norway
Mean Range
Phthalate species Total dust Organic fraction Total dust Organic fraction
Dibutyl phthalate 10 12 1-103 1-117
Benzylbutylphthalate 11 14 0-44 0-48
Di(2-ethylhexyl) phthalate 64 82 10-161 11-210
Diethyl phthalate 1 1 0-11 0-17
Diisobutyl phthalate 1 1 0-30 0-45
Heavier phthalatesa 10 12 0-138 0-161
Total phthalate 96 123 13-292 17-327
Values are given in pg/100 mg sedimented dust.
aMixture of isomeric dinonyl phthalates.
Table 2. Phthalate concentrations adsorbed to sus-
pended particulate matter in six dwellings in Oslo,
Norway
Phthalate species Mean± SD Range
Dibutylphthalate 37±22 13-69
Benzyl butyl phthalate 14 ± 30 0-75
Di(2-ethylhexyl) phthalate 60 ± 30 24-94
Diethyl phthalate 8± 9 0-24
Diisobutyl phthalate 0 ± 0 0-0
Heavierphthalatesa 0±0 0-0
Total phthalate 118 ± 63 45-226
SD, standard deviation. Values are given in pgi/100
mg suspended particulate matter.
aMixture of isomeric dinonyl phthalates.
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exposure of DEHP adsorbed to suspended
particulate matter is one- to threefold the
estimated daily vapor phase exposure in the
general population. This estimation must be
considered as conservative because, under
normal housing activities, thePMIO fraction
of total suspended particles may be only
about 60%, due to strong resuspension
effects ofhousing activities (4Z). The calcu-
lated ratio of one- to threefold particulate
exposure compared to vapor phase exposure
must be interpreted as approximate, due to
the very limited data on DEHP vapor phase
levels in indoor air and because we have not
performed parallel measurements of the
vapor phase concentrations in the indoor
environments under study. Infants per kilo
weight have a respirational volume twice as
large as adults (39) and spend most of the
time indoors and, in particular, in bed-
rooms. Children's bedrooms are often small
rooms and with one door and one window
only. A small room has a higher wall surface
to room volume ratio than a large room;
thus, the emission from building materials is
highest in a small room. Hence, small chil-
dren are subject to the highest exposure risk.
The particulate inhalation exposure to
DEHP is considered to be the most signifi-
cant because ofits low clearance and exten-
sive penetration into the pulmonary region
and its capability ofcreating high local con-
centrations in the airways at the deposition
site, with subsequent local effects; the sum
of these local effects could become severe.
However, we found no studies regarding
such local high concentrations.
Exposure to DEHPandpossible mecha-
nisms involved in thepathogenesis ofasth-
ma. The plasticizer DEHP is widely used in
the production of PVC and vinyl chloride
resins and accumulates to a great extent in
building interior surfaces (33,34). The use
of PVC flooring in Norway is estimated to
be 8 million m2/year (34). This is about
four times the per capita use of PVC floor-
ing in Europe as a whole (34). DEHP may
constitute 40% or more ofthe plastic prod-
uct. In industrialized countries, approxi-
mately 50% ofphthalate esters are estimated
to accumulate in buildings as compounds in
different building and interior materials
(33). The increased use of phthalate esters
has occurred simultaneously with the report-
ed increase in asthma. However, we found
no studies regarding time trends in indoor
air exposure to DEHP. The causality in this
correlation is therefore unknown.
The development ofbronchial hyperreac-
tivity/hypersensitivity and asthma is assumed
to be attributable to several factors. The
inflammatory process, with epithelium dam-
age and edema, is a suggested contributor in
pathogenesis (43,44). The inflammatory
mediators prostaglandin (PG) D2 and throm-
boxanes have avarietyofeffects on targetcells
in the airways, which may be relevant in the
etiology of asthma. PGD2 induces a pro-
nounced contraction of human airway
smooth muscle and increases the bronchial
sensitivity (43,45,46). This is supported by
evidence that PGD2 is released in vivo in the
human lower respiratory tract after acute
allergic challenge (47). PGD2 is preferentially
metabolized by the human lung to 9a,11p
prostaglandin F2 (9a,11 PGF2), which also
has bronchoconstrictive characteristics.
Although 9a,11 3PGF2 is less potent than
PGD2, it is assumed to have a larger effect in
the lung because ofslower degradation (48).
All the contractive prostaglandins and throm-
boxanes react via an apparent single throm-
boxane (TP) A2 receptor (49,50). Other TP
receptor subtypes may exist, which could
explainwhy the TP receptor is not veryselec-
tive; however, strong evidence supports the
existence ofa single form ofthe TP receptor
in both platelets and smooth muscle cells (5).
Receptor binding is suggested as contributing
actively to the pathogenesis ofbronchial asth-
ma (7,45,46).
We propose that the increase in asthma
is due to contributory factors of environ-
mental chemicals in general, and specifically
DEHP through its primary hydrolysis
product MEHP, which affects the bronchial
contracting receptors and thereby generates
a hyperreactive condition in the lungs. This
will increase the risk ofa pathological devel-
opment in addition to aggravation of the
effects ofother environmental agents.
The bronchial contracting prostaglandin
receptors are particularly sensitive to environ-
mental chemicals for the following reasons:
* Under normal conditions the inflamma-
tory mediators PGD2 and 9c,11PPGF2
Table 3. Spearman correlation coefficients between plasticizer concentrations in sedimented dust (total and
organic fraction) and suspended particulate matter
Total sedimented dust vs. Organic fraction vs.
Plasticizer species suspended particulate matter suspended particulate matter
Dibutyl phthalate 0.03 (p = 0.96) -0.09 (p = 0.87)
Benzyl butyl phthalate 0.85 (p<0.05) 0.85 (p<0.05)
Di(2-ethylhexyl) phthalate 0.83 (p<0.05) 0.83 (p<0.05)
Diethyl phthalate 0.13 (p = 0.80) 0.13 (p = 0.80)
Diisobutyl phthalate 0.66 (p = 0.16) 0.43 (p = 0.40)
Two-tailed significance levels are given in parentheses.
are rapidly metabolized by specialized
enzymes in lung tissues. MEHP is not
equally suited to be metabolized by these
enzymes and, in consequence, will affect
the receptors over longer periods. This
indicates that environmental chemicals
are not required to be particularly potent
bronchial contractors in order to exhibit
a marked effect on lung tissues.
* The bronchial contracting prostaglandin
receptors are suggested to be relatively
unspecific.
As shown in Figure 3, there is a struc-
tural similarity between DEHP, MEHP,
and the prostaglandins, regarding both the
molecular size and ring structure. This
favors DEHP and MEHP as the possible
active species in the recent observed associa-
tion between PVC interior surface materials
and bronchial obstruction Jaakkola et al.,
unpublished data). The bronchial contract-
ing prostaglandin receptors are suggested to
be relatively unspecific. Recently, the TP
receptor has been analyzed and the amino
acid sequence and three-dimensional struc-
ture model has been elucidated (6). The
receptor is composed of a hydrophobic
pocket embedded in the cell membrane and
a hydrophilic extracellular part. When the
receptor is stimulated by a prostaglandin, it
is assumed that the ring structure is embed-
ded in the hydrophobic pocket. It is proba-
bly the stimulation of the hydrophobic
pocket, which elicits the signal transmis-
sion. Xenobiotics that fit into this pocket
could probably produce a response. Among
xenobiotics there are some obvious candi-
dates, e.g., phthalates, adiapates, alkylben-
zens, nonylphenols, and others.
The lung toxicological information for
DEHP indicates that intravenous adminis-
tration of DEHP and its hydrolysis prod-
uct MEHP accumulate in the lungs of rats
(51). Intravenous injection of DEHP in
rats will result in tracheal bleeding, tracheal
inflammation, and rapid death (52). Based
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Figure 2. Correlation between the amount of di(2-
ethylhexyl) phthalate (DEHP) in suspended partic-
ulate matter(PM1O) and the DEHP concentrations
in total sedimented house dust and the organic
fraction ofsedimented house dust.
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Figure 3. Structural similarities between proposed xenobiotics (DEHP and MEHP) and inflammation
prominent mediators as prostaglandins and thromboxanes. Abbreviations: DEHP, di(2-ethylhexyl) phtha-
late; MEHP, mono(2-ethylhexyl) phthalate; PGD2, prostaglandin 02; 9.Ct11 PGF2I 9a 11) prostag.andin F2;
PGF2o,I prostaglandin F2oa;TX2 thromboxane A2.
on data from both human and animal
studies, the metabolism of DEHP involves
a complex series of reactions with the pro-
duction of30 or more metabolites, but the
primary metabolite is MEHP (41). DEHP
is partially hydrolyzed to MEHP, followed
by oxidation of the remaining side chain
(53). No data were located regarding the
rnetabolites produced in humans or ani-
mals after inhalation exposure to DEHP,
but the metabolism following this route of
exposure is expected to be similar to that
after oral exposures because lipases are pre-
sent in the alveolar cells ofthe lungs (41).
No studies were located regarding respira-
tory effects in general human populations
after inhalation exposure to DEHP.
Inhalation of DEHP during respiration
therapy ofpreterm infants (unintentionally
administered through PVC respiratory tub-
ing systems) has been reported to increase
the risk of bronchial asthma (53). This
must be considered as an almost pure vapor
phase exposure to DEHP due to the highly
effective filters in the respiratory tubing
system. The pharmacological effects of
DEHP and its metabolites MEHP and
phthalic acid on rat muscarinic receptor
response have also been studied (35).
Methacholine dose-response curves of rat
tracheal tissue were not influenced by
DEHP or phthalic acid (up to concentra-
tions of 1 mM), but incubation with 0.1
mM MEHP induced a significant increase
in bronchial sensitivity. The absence of
similar effects of DEHP is explained by its
high lipophilicity, rendering it unable to
reach its site(s) ofaction. With exposure to
DEHP particulate matter in concentrations
found in the present study, the effective
MEHP dose of0.1 mM in rats (35) is con-
sidered likely to occur locally in human tra-
cheal tissue too.
Asthma becomes manifest through pul-
monary inflammation and increased non-
specific reactivity to several stimuli.
Clinically, this hyperreactivity is observed
by stimulating the lungs with nonspecific
stimuli such as histamine or methacholine
in a concentration that produces the same
bronchial contractive effects. In a clinical
sense, bronchial hyperreactivity is a conse-
quence of two different phenomena: 1)
hypersensitivity implies a normal response
to lower than normal concentrations ofthe
challenging agent, corresponding to a left
90.
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Figure 4. Principal normal cumulative log
dose-response curve, illustrated as percent con-
traction of tracheal tissue due to challenge with
methacoline. Hyperreactivity is defined as an
abnormal increase in the maximum response
obtained by an increase in the concentration of
the active agent, while hypersensitivity implies a
normal response to a lower than normal concen-
tration ofthe challenging agent(54). EC50, median
effective concentration.
parallel shift in the log dose-response
curve; and 2) hyperreactivity is defined as
an abnormal increase in the maximum
response obtained by an increase in the
concentration of the active agent (steeping
in the slope ofthe log dose-response curve
and increase of amplitude) (54). This is
illustrated in Figure 4.
Doelman et al. (51) have shown that
MEHP, in in vitroexperiments with rat tra-
cheal tissue, induces a dose-dependent
decrease in log median effective concentra-
tion (EC50) for methacholine curves, in
other words, a dose-dependent increase in
respiratory sensitivity. Doelman et al. (51)
also showed that the level of respiratory
hyperreactivity declined with relatively high
concentrations ofMEHP. Both DEHP and
MEHP have been reported to be effective
inhibitors of the protein kinase C enzyme,
which is involved in both the muscarinic
and TP receptor transduction pathways
(5,51,55). This is illustrated in Figure 5.
To investigate whether the hypersensi-
tivity following MEHP exposure is due to
protein kinase C, Doelman et al. (51) test-
ed the effects ofthe known specific protein
kinase C inhibitor 1(5-isoquinolinyl-
sulphonyl)2-methylpiperazine (H7) on the
methacholine dose-response curve of the
rat trachea. Incubation with H7 induced a
decrease in maximal effect, i.e., a decrease
in hyperreactivity, but did not influence
the hypersensitivity. The authors conclud-
ed that a decrease in log EC50 following
exposure to MEHP was not due to protein
kinase C inhibition, whereas the reduction
of the maximum effect (hyperreactivity)
with high levels ofMEHP might be.
These results support the proposed
mechanisms involved with DEHP expo-
sure. Ifour hypothesis about mechanisms is
Volume 105, Number9, September 1997 * EnvironmentalHealth Perspectives 976Articles * Plasticizers as risk factors in asthma
_TP _ *M _
Proten
kinase C
Contraction of
smooth muscle
Figure 5. The general contraction as described
by Doelman et al. (51) is due to stimulation of the
muscarine receptor (M) by acetylcholine. An
additional contraction effect is proposed by
mono(2-ethylhexyl) phthalate (MEHP) stimulation
of thromboxane A2 receptor (TP). Both receptors
are known to activate protein kinase C.
correct, MEHP exposure will result in a
dose-dependent stimulation of the TP
receptor leading to increased hypersensitiv-
ity. With higher concentrations ofMEHP,
it is possible that an inhibition of protein
kinase C will result in a corresponding
decline in hyperreactivity. A single receptor
may be involved in the parallel left shift of
the log EC50 curve after MEHP exposure.
A decline in the hyperreactivity is most
often associated with a restricted signal
transfer from the receptor to the effector
(54). A final proofofthe proposed hypoth-
esis could be achieved by preventing the
MEHP-induced hypersensitivity by adding
a TP receptor antagonist such as BAY
u3405, which is a selective competitive
antagonist (56).
A likely modifier in the relationship
between inhalation exposure to DEHP and
asthma is dietary intake of omega-3
polyunsaturated fatty acids (PUFA).
Several studies have shown dietary intake
of PUFA to have anti-inflammatory prop-
erties (57,58). The anti-inflammatory
effect of PUFA is due to the fact that the
inflammatory mediators thromboxane A3
(TXA) and leukotriene B5 (LTB5) synthe-
sized?rom PUFA give rise to lower biologi-
cal effects than corresponding mediators
(TXA2 and LTB4) derived from arachidon-
ic acid (59). Ifthe dietary intake of PUFA
is insufficient, then cellular response will
increase and may therefore contribute to
increased respiratory hyperreactivity. We
have found that exposure to plasticized
materials in residences increases the risk of
bronchial obstruction in young children
Jaakkola et al., unpublished data). Further
analysis reveals that dietary intake ofPUFA
is a strong modifier which supports the
hypothesis ofDEHP exposure as the active
agent in the association between exposure
to plastisized materials and bronchial
obstruction in young children. Further, it
supports the proposed mechanisms of
effect as described in this study.
In conclusion, we have shown that sus-
pended particle exposure to the plasticizer
DEHP is one- to threefold higher than the
estimated vapor phase exposure and that
previous estimates of daily airborne intake
are underestimated because the particle
fraction is overlooked. Further, the possible
mechanisms ofrespiratory effects by inhala-
tion exposure to DEHP has been elaborat-
ed. DEHP is primarily hydrolyzed to
MEHP, followed by oxidation of the
remaining side chain. The proposed mecha-
nism ofeffect states that MEHP mimics the
inducing prostaglandins PGD2, 9a,11 I
PGF2, andPGF2. and thromboxanes in the
lungs, thereby increasing the risk of induc-
ing inflammation in the airways, which is a
characteristic feature ofasthma.
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